1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Rubix Strategies LLC

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

MA US

Primary Industry

Biotechnology

About

Founded in 2016 and based in Massachusetts, US, Rubix Strategies LLC, doing business as Rubix LS, operates as a life science research and development firm for rare diseases, infectious diseases, and environmental diseases. The firm also provides an online platform for clinical trials and therapeutic programs.
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Healthcare IT, Medical Devices & Equipment, Specialty Pharmaceuticals, Pharmaceutical Research & Development, Medical Software, Analytics & Performance Software
Website
www.rubixls.com
Verticals
Blockchain, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Deals

Deals Type
Add-on, Trade Sale
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Edunation Ltd 26 Mar 2024
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.